Prot #PR1-C82T-3101: A Randomized, Double-Blind, Placebo-Controlled Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial

Project: Research project

Project Details

StatusFinished
Effective start/end date5/7/155/7/16

Funding

  • PRISM Pharma Co., Ltd. (Prot #PR1-C82T-3101)